SELLAS Life Sciences Group, Inc. (SLS) Tops Q2 EPS by 5c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q2 EPS of ($0.31), $0.05 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• CLSA Starts Beike (BEKE) at Outperform (2)
• SK hynix approves ₩40 trillion share buyback and cancellation plan